Core Laboratories N.V.
    SEC Filings

    |
    |

    All SEC filings by Core Laboratories N.V. — annual and quarterly reports, current reports, registrations, proxies and ownership forms, updated in real time.

    Financials

    10-QQuarterly reportView DiffApr 27, 2023
    10-KAnnual reportView DiffFeb 9, 2023
    10-QQuarterly reportView DiffOct 27, 2022
    10-QQuarterly reportView DiffJul 28, 2022
    10-QQuarterly reportView DiffApr 28, 2022
    10-KAnnual reportView DiffFeb 10, 2022
    10-QQuarterly reportView DiffOct 29, 2021
    10-QQuarterly reportView DiffJul 30, 2021
    10-QQuarterly reportView DiffApr 23, 2021
    10-KAnnual reportView DiffFeb 8, 2021

    Events

    8-KResults of Operations and Financial ConditionApr 26, 2023
    8-KSubmission of Matters to a Vote of Security HoldersApr 3, 2023
    8-KQ4 2022 Earnings Conference CallFeb 3, 2023
    8-KFourth Quarter Revenue of $128 Million; up Slightly SequentiallyFeb 1, 2023
    8-KCore Lab Announces Proposed Redomestication to the United StatesJan 17, 2023
    8-KCore Lab Announces Voluntary Delisting From Euronext AmsterdamNov 4, 2022
    8-KThird Quarter Revenue of $126 Million; up 4% Sequentially; up 7% Year-Over-YearOct 26, 2022
    8-KSecond Quarter Revenue of $120.9 Million; up 5% Sequentially; up 2% Year-Over-YearJul 27, 2022
    8-KEntry Into a Material Definitive AgreementJul 26, 2022
    8-KCore Lab Announces $60,000,000 “at-The-Market” Equity Offering ProgramJun 9, 2022

    Registrations and Prospectuses

    15F-12GSecurities registration termination (foreign)May 12, 2023
    25-NSEExchange delistingMay 2, 2023
    S-8 POSRegistration of securities for employees (post-effective amendment)May 1, 2023
    S-8 POSRegistration of securities for employees (post-effective amendment)May 1, 2023
    S-8 POSRegistration of securities for employees (post-effective amendment)May 1, 2023
    S-8 POSRegistration of securities for employees (post-effective amendment)May 1, 2023
    S-8 POSRegistration of securities for employees (post-effective amendment)May 1, 2023
    S-8 POSRegistration of securities for employees (post-effective amendment)May 1, 2023
    S-8 POSRegistration of securities for employees (post-effective amendment)May 1, 2023
    S-8 POSRegistration of securities for employees (post-effective amendment)May 1, 2023

    Proxies

    DEFA14AAdditional proxy soliciting materialsApr 27, 2023
    DEF 14ADefinitive proxyView DiffApr 27, 2023
    DEFM14AProxy related to mergerFeb 28, 2023
    DEFA14AAdditional proxy soliciting materialsMar 24, 2022
    DEF 14ADefinitive proxyView DiffMar 22, 2022
    PRE 14APreliminary proxyView DiffMar 11, 2022
    DEF 14ADefinitive proxyView DiffMar 19, 2021
    DEFA14AAdditional proxy soliciting materialsMar 19, 2021
    PRE 14APreliminary proxyView DiffMar 5, 2021
    DEFA14AAdditional proxy soliciting materialsMay 11, 2020

    Other

    UPLOADLetter from SECJun 9, 2022
    CORRESPCorrespondence with SECJun 7, 2022
    CORRESPCorrespondence with SECJun 2, 2022
    SDConflict minerals disclosureMay 24, 2022
    UPLOADLetter from SECMay 18, 2022
    SDConflict minerals disclosureMay 28, 2021
    SDConflict minerals disclosureMay 21, 2020
    SDConflict minerals disclosureMay 28, 2019
    SDConflict minerals disclosureMay 29, 2018
    SDConflict minerals disclosureJun 1, 2017

    Ownership

    SC 13G/ACore Laboratories N VJun 12, 2023
    4Dijken Eeuwijk Monique VanApr 3, 2023
    4Kwaku TemengApr 3, 2023
    4Michael StraughenApr 3, 2023
    4Katherine MurrayApr 3, 2023
    4Harvey Robert KlingensmithApr 3, 2023
    4Martha Z. CarnesApr 3, 2023
    4Mark Damian TattoliFeb 21, 2023
    4Christopher Scott HillFeb 21, 2023
    4Gwendolyn GreshamFeb 21, 2023